![Christopher Prentiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Prentiss
Director of Finance/CFO at
MANNKIND CORPORATION
Net worth: 854 692 $ as of 30/03/2026
Profile
Christopher B. Prentiss is Chief Financial Officer & Director at scPharmaceuticals, Inc. since 2025.
Mr. Prentiss is Chief Financial & Accounting Officer at MannKind Corp.
since 2024.
Former roles include Chief Financial Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, Vice President-Finance & Controller at InterMune, Inc. from 2013 to 2015, Controller at Dynavax Technologies Corp.
from 2012 to 2013, Senior Manager at KPMG LLP from 1997 to 2005, Controller at MannKind Corp., and Chief Financial Officer at ADARx Pharmaceuticals, Inc. Education includes an MBA from Indiana University and an undergraduate degree from Loyola Marymount University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MANNKIND CORPORATION 0.11% | 22/03/2026 | 348,854 ( 0.11% ) | 854 692 $ | 30/03/2026 |
Christopher Prentiss active positions
| Companies | Position | Start |
|---|---|---|
| MANNKIND CORPORATION | Director of Finance/CFO | 21/04/2024 |
| SCPHARMACEUTICALS INC. | Director of Finance/CFO | 06/10/2025 |
Former positions of Christopher Prentiss
| Companies | Position | End |
|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Director of Finance/CFO | 23/11/2021 |
| INTERMUNE INC | Comptroller/Controller/Auditor | 28/02/2015 |
| DYNAVAX TECHNOLOGIES CORPORATION | Comptroller/Controller/Auditor | 31/05/2013 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 30/06/2005 |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Director of Finance/CFO | - |
Training of Christopher Prentiss
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
MannKind Corp.
 MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola Marymount University
 Loyola Marymount University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
- Stock Market
- Insiders
- Christopher Prentiss
